Navigation Links
Yaz and Yasmin Birth Control Lawsuits Continue to Mount,The Onder Law Firm Will Provide a Free Case Review to Women Suffering from Yaz Side Effects
Date:11/12/2009

It is estimated that legal counsel already represents over 3,500 women and countless others are still in need of help, unaware of their rights, if Yaz, the most popular birth control pill in the United States, affected them adversely. The Onder Law Firm will provide a free case review to women or the families of women who have suffered from serious health problems after taking Yaz.

St. Louis, MO (Vocus) November 12, 2009 -- The number of Yaz lawsuits continues to increase as women suffering from health problems ranging from gallbladder disease to stroke and heart attack come forward and seek legal representation. In some cases it is the families of women having died. The brief history of the best selling birth control pill in the United States contains multiple FDA warning letters, advertising retractions for minimizing risk and overstating benefits and a requirement to have all advertising through 2015 approved by the FDA. Yaz is manufactured by Bayer HealthCare Pharmaceuticals, Inc.

The FDA and Attorneys General of 27 states required Bayer HealthCare Pharmaceuticals, Inc. to correct deceptive advertising, which minimized serious health risks to users and overstated the symptoms for which the drug was approved to treat.    This prompted the company to launch a $20 million ad campaign to correct those misstatements and omissions. The 2009 Warning Letter was not the first the makers of Yaz received from the FDA, additional communications were sent in 2008 and even date back as far as 2003. The 2008 FDA Yaz Warning Letter to Bayer HealthCare Pharmaceuticals, Inc. regarding Yaz advertising specifically cited the company’s failure to disclose serious health risks. The letter states “there are numerous warnings associated with the use of Yaz including, but not limited to, venous and arterial thrombotic and thromboembolic events (such as myocardial infarction, thromboembolism, stroke), hepatic neoplasia, gallbladder disease, and hypertension. Moreover, Yaz has additional risks because it contains the progestin, drospirenone. Drospirenone has antimineralocorticoid properties which can lead to hyperkalemia in high risk patients, which may result in potentially serious heart and health problems. Women taking Yaz must be concerned about the drug interactions that could increase potassium, in addition to the drug interactions common to all combination oral contraceptives.” Hyperkalemia is a medical condition where the blood has abnormally elevated levels of potassium. Severe hyperkalemia can cause blood clots, resulting in problems such as stroke, heat attack (myocardial infarction) or deep vein thrombosis. These are the health problems that have been most commonly cited in currently filed Yaz lawsuits.

The Onder Law Firm wants women who have used or are using Yaz or Yasmin to be aware of the side effects and hazards. The firm’s Yaz safety information web site contains information regarding Yaz side effects and rights women suffering from them may have. The attorneys of The Onder Law Firm will review will provide free case review to women having experienced side effects or medical problems after taking Yaz. The Onder Law Firm provides experienced legal representation without fee unless it collects for its clients.

About The Onder Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O’Leary & Peterson has represented clients throughout the United States in pharmaceutical litigation such as Vioxx, Digitek, Ethex and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit www.onderlaw.com or call 1-877-ONDER-LAW.

###

Read the full story at http://www.prweb.com/releases/yaz/lawsuits/prweb3195174.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Pennsylvania Poised to be Center of State Court Yaz(R) Yasmin(R) Ocella(R) Birth Control Litigation
2. Ohio Law Firm Warns of Birth Control Pill YAZ/Yasmin Side Effects Lawsuits
3. Motion Filed to Consolidate Yasmin/YAZ Litigation in Toledo, Ohio
4. Burg Simpson Files Yasmin/Yaz Lawsuits
5. Barr and Bayer Sign Supply and Licensing Agreements for Launch of Generic Yasmin(R) and Yaz(R) Oral Contraceptives
6. CDC Study Links 2 Antibiotics to Birth Defects
7. Asians Seem to Suffer Less During Childbirth
8. New IVF Guidelines Aim to Reduce Multiple Births
9. Jack LaLanne Celebrated as Fitness Icon at Star-Studded Birthday Bash
10. Birth Control Pills Might Alter Mate Selection: Study
11. Antidepressants May Be Linked to Birth Problems
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Yaz and Yasmin Birth Control Lawsuits Continue to Mount,The Onder Law Firm Will Provide a Free Case Review to Women Suffering from Yaz Side Effects
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the ... of funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... base and accelerate its technology and product roadmap. , “Jvion is ...
(Date:4/29/2016)... ... 2016 , ... CURE Media Group , the nation’s ... today announced that Lynne Malestic, RN, of Eisenhower Lucy Curci Cancer Center in ... Oncology Nursing , which honors nurses who have dedicated their careers to helping ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, Inc. ... line of probiotics, Petbiotics ™, as they fondly call them. As animal ... groups networking for their non-profit organizations. Animal rescues across the nation face huge ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, participated in ... efficacy of the Sarepta Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... 2014. Each year, reproductive endocrinologists are required to report in vitro fertilization ... of professionals dedicated to the practice of assisted reproductive technologies in the United ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 ... H1 2016" is a report that provides an ... strengthen R&D pipelines by identifying new targets and ... Company Profiles discussed in this H1 2016 ... Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx ...
(Date:4/27/2016)... le 27 Avril 2016 ... progressé de +5% sur le trimestre, soutenu par ... consommables  Croissance de +16% des ventes ... Mauna Kea Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : ... laser, annonce aujourd,hui son chiffre d,affaires pour le ...
(Date:4/27/2016)... 27, 2016 Transparency Market Research ... Market - Global Industry Analysis, Size, Share, Growth, Trends, ... the global skincare devices market was valued at US$ ... at a CAGR of 10.1% from 2015 to 2023 ... Browse the full Skincare Devices Market (Treatment Device - LED ...
Breaking Medicine Technology: